HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked decrease of plasma VEGF after implantation of autologous bone marrow mononuclear cells in a patient with critical limb ischemia--a case report.

Abstract
The authors performed autologous bone marrow mononuclear cells implantation (BMI) in a 79-year-old man with critical limb ischemia. After BMI, the resting pain of the ischemic leg improved gradually. They measured the plasma concentrations of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and serum hepatocyte growth factor (HGF) in the blood from bilateral femoral veins. Before BMI, the plasma VEGF and bFGF concentrations were much greater in the ischemic leg than in the other lower limb, but decreased to the same concentrations as those in the contralateral lower extremity after BMI. The large concentrations of the angiogenic factors VEGF and bFGF in plasma indicate the severity and extent of the leg ischemia. BMI resulted in lower levels of VEGF and bFGF, and this fall is the hallmark of the effectiveness of BMI in the treatment of peripheral artery disease.
AuthorsTakuya Ozawa, Kiminori Kato, Hirofumi Sanada, Yashiro Makiyama, Takashi Saigawa, Satoru Souda, Shigeo Hashimoto, Tatsuo Furukawa, Ken Toba, Makoto Kodama, Hiroshi Fujiwara, Osamu Namura, Junichi Hayashi, Nobuhiko Yoshimura, Yoshifusa Aizawa
JournalAngiology (Angiology) 2006 Mar-Apr Vol. 57 Issue 2 Pg. 235-9 ISSN: 0003-3197 [Print] United States
PMID16518534 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers
  • Vascular Endothelial Growth Factor A
Topics
  • Aged
  • Biomarkers (blood)
  • Bone Marrow Transplantation (methods)
  • Enzyme-Linked Immunosorbent Assay
  • Femoral Artery (diagnostic imaging)
  • Follow-Up Studies
  • Humans
  • Ischemia (blood, diagnostic imaging, surgery)
  • Leg (blood supply)
  • Male
  • Monocytes (transplantation)
  • Radiography
  • Transplantation, Autologous
  • Vascular Endothelial Growth Factor A (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: